🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Santa Claus Rally: 2 Growth Stocks on the Move Again!

Published 2020-12-22, 09:05 a/m
Santa Claus Rally: 2 Growth Stocks on the Move Again!

Gone are the days when we need to go physically to the physician for simple consultations thanks to companies like WELL Health Technologies (TSX:WELL) and CloudMD Software & Services (TSXV:DOC) that are transforming the traditional healthcare industry.

In the last few months, the growth stocks sold off as much as 15% and 30%, respectively. However, there’s been renewed interest in the form of an early Santa Claus Rally in the growth stocks that are taking part in the eHealth transformation.

Interested investors should take a closer look, and buy shares before they climb even higher.

WELL Health stock Much of the WELL Health management team, including the founder and CEO, Hamed Shahbazi, previously built TIO Network from the ground up before it was acquired by Paypal in 2017. Shahbazi and his team are here to solve another problem — modernizing our healthcare system with technology.

WELL Health’s omni-channel clinical network provides flexibility for in-person or virtual consultation. When there was an economic lockdown in British Columbia in Q2, patients limited their visits to the physical clinics. In-person consultation shrunk to 37% of total visits. Thankfully, it supported telehealth visits (via VirtualClinic+ and phone consultation) to fill in the gap.

When the economy reopened in Q3, the percentage of in-person visits rebounded strongly to 49% of total visits, which increased by 19% against Q2, while the number of telehealth visits remained steady.

Post-pandemic, WELL Health sees telehealth retaining 40-50% of total patient visits. The benefit is that telehealth saves hours of patients’ time (from travelling to the clinic and waiting for the previous patient to finish up) for something like a quick prescription renewal.

WELL Health posted record revenue of $12.2 million in Q3, up 50% year over year (YOY). The strong revenues are primarily due to making strategic acquisitions and the addition of telehealth-related revenue.

Notably, digital services revenue increased a whopping 149% YOY, contributing to about 20% of total revenue, up from roughly 12% a year ago, which also resulted in gross margin expansion by 17%, against Q3 2019, to 41.2%.

CloudMD stock After its recent acquisitions, including the seven announced in Q3, CloudMD would be about half the size of WELL Health based on annualized run-rate revenue.

CloudMD’s record Q3 revenue of $3.4 million was 55% higher year over year. Digital services revenue makes up about 15% of total revenues, down from about 18% a year ago. Its Q3 gross margin was 42%, down from 46% a year ago.

A lower percentage of digital services revenue and compression in the margin were due to the type of acquisitions it completed in the past year. They were primarily clinic services and pharmacies, which have a lower margin compared to digital services.

Rest assured. CloudMD’s subsequent acquisitions have been more focused on digital services and enterprise health solutions, which should help expand margins. It has its sights set for a gross margin of 50% down the road.

More upside coming in the Santa Claus Rally WELL Health consolidated at $7 per share for a while before it popped 12% to $7.84. Analysts think the stock can trade at about 28% higher within the next 12 months.

Additionally, more growth is set to come as the company embarks on the journey to modernize the healthcare industry. Its latest acquisition in the works is Adracare, which will expand its offerings in the areas of mental health and cannabis therapy on top of its existing offerings in electronic medical records (EMR) and telehealth. Before this acquisition, the company had an annualized run-rate revenue of $68 million.

CloudMD stock double bottomed at $2.07 per share, in the last month, before appreciating 30% to $2.70. Analysts think the stock should be worth about 23% higher within the next 12 months.

Consider buying the cheap stocks before more money flows into the growing eHealth industry. If the two companies execute their strategies well, analysts will increase their price targets.

The post Santa Claus Rally: 2 Growth Stocks on the Move Again! appeared first on The Motley Fool Canada.

Fool contributor Kay Ng owns shares of CloudMD and WELL Health.

The Motley Fool’s purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool Canada’s free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. Motley Fool Canada 2020

This Article Was First Published on The Motley Fool

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.